These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 19591199

  • 1. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
    Witte ME, Bø L, Rodenburg RJ, Belien JA, Musters R, Hazes T, Wintjes LT, Smeitink JA, Geurts JJ, De Vries HE, van der Valk P, van Horssen J.
    J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of osteopontin and alphaBeta-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays.
    Sinclair C, Mirakhur M, Kirk J, Farrell M, McQuaid S.
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):292-303. PubMed ID: 15885066
    [Abstract] [Full Text] [Related]

  • 3. Multiple sclerosis: a protective or a pathogenic role for heat shock protein 60 in the central nervous system?
    Raine CS, Wu E, Ivanyi J, Katz D, Brosnan CF.
    Lab Invest; 1996 Jul; 75(1):109-23. PubMed ID: 8683935
    [Abstract] [Full Text] [Related]

  • 4. Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.
    Wolswijk G, Balesar R.
    Brain; 2003 Jul; 126(Pt 7):1638-49. PubMed ID: 12805111
    [Abstract] [Full Text] [Related]

  • 5. Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes.
    Holley JE, Newcombe J, Winyard PG, Gutowski NJ.
    Mult Scler; 2007 Sep; 13(8):955-61. PubMed ID: 17623739
    [Abstract] [Full Text] [Related]

  • 6. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis.
    Geurts JJ, Wolswijk G, Bö L, van der Valk P, Polman CH, Troost D, Aronica E.
    Brain; 2003 Aug; 126(Pt 8):1755-66. PubMed ID: 12805104
    [Abstract] [Full Text] [Related]

  • 7. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis.
    Leech S, Kirk J, Plumb J, McQuaid S.
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):86-98. PubMed ID: 17239011
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N, Bö L, Hoek RM, Huitinga I.
    Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
    [Abstract] [Full Text] [Related]

  • 9. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
    Gehrmann J, Banati RB, Cuzner ML, Kreutzberg GW, Newcombe J.
    Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
    [Abstract] [Full Text] [Related]

  • 10. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
    Nijland PG, Michailidou I, Witte ME, Mizee MR, van der Pol SM, van Het Hof B, Reijerkerk A, Pellerin L, van der Valk P, de Vries HE, van Horssen J.
    Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of distinct galectins in multiple sclerosis lesions.
    Stancic M, van Horssen J, Thijssen VL, Gabius HJ, van der Valk P, Hoekstra D, Baron W.
    Neuropathol Appl Neurobiol; 2011 Oct; 37(6):654-71. PubMed ID: 21501208
    [Abstract] [Full Text] [Related]

  • 12. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
    Cunnea P, McMahon J, O'Connell E, Mashayekhi K, Fitzgerald U, McQuaid S.
    Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
    [Abstract] [Full Text] [Related]

  • 13. [The evidence for primary axonal loss in multiple sclerosis].
    Anthony DC, Hughes P, Perry VH.
    Rev Neurol; 2010 May; 30(12):1203-8. PubMed ID: 10935251
    [Abstract] [Full Text] [Related]

  • 14. Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis.
    Bizzozero OA, DeJesus G, Callahan K, Pastuszyn A.
    J Neurosci Res; 2005 Sep 01; 81(5):687-95. PubMed ID: 16007681
    [Abstract] [Full Text] [Related]

  • 15. The blood-brain barrier in cortical multiple sclerosis lesions.
    van Horssen J, Brink BP, de Vries HE, van der Valk P, Bø L.
    J Neuropathol Exp Neurol; 2007 Apr 01; 66(4):321-8. PubMed ID: 17413323
    [Abstract] [Full Text] [Related]

  • 16. Differences in expression of junctional adhesion molecule-A and beta-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology.
    Padden M, Leech S, Craig B, Kirk J, Brankin B, McQuaid S.
    Acta Neuropathol; 2007 Feb 01; 113(2):177-86. PubMed ID: 17024496
    [Abstract] [Full Text] [Related]

  • 17. Axonal transection in the lesions of multiple sclerosis.
    Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L.
    N Engl J Med; 1998 Jan 29; 338(5):278-85. PubMed ID: 9445407
    [Abstract] [Full Text] [Related]

  • 18. Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions.
    van Horssen J, Drexhage JA, Flor T, Gerritsen W, van der Valk P, de Vries HE.
    Free Radic Biol Med; 2010 Nov 01; 49(8):1283-9. PubMed ID: 20673799
    [Abstract] [Full Text] [Related]

  • 19. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
    Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, Mattioda A, Tribolo A, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P.
    J Neuropathol Exp Neurol; 2009 May 01; 68(5):489-502. PubMed ID: 19525897
    [Abstract] [Full Text] [Related]

  • 20. Identification and investigation of mitochondria lacking cytochrome c oxidase activity in axons.
    Zambonin J, Engeham S, Campbell GR, Ziabreva I, Beadle NE, Taylor RW, Mahad DJ.
    J Neurosci Methods; 2010 Sep 30; 192(1):115-20. PubMed ID: 20659500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.